Neurothrombectomy devices Market By Product Type (Clot Retrieval Devices, Aspiration Devices, Snares), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The neurothrombectomy devices market was valued at $481.1 million in 2021, and is estimated to reach $1,192.26 million by 2031, growing at a CAGR of 9.5% from 2022 to 2031.
Neurothrombectomy is a surgical procedure in which blood clot is removed from blood vessel. A blood clot in the brain can cause an ischemic stroke, which is caused by an artery to the brain becoming blocked and starving a portion of the brain of oxygen and nutrients. A clot in the brain can further cause a buildup of cellular waste and carbon dioxide because the brain will be unable to clear this waste properly. This can cause the cells around the blockage to die, and the neurons in this portion of the brain to stop working, thus, resulting in damage throughout the body. Neurothrombectomy is used to treat acute ischemic stroke, which is associated with poor outcomes and high health care burden.
The growth of the global neurothrombectomy devices market is majorly driven by surge in incidence of acute ischemic stroke along with the demand for minimally invasive procedures and increase in cases of head injuries due to motor vehicle accidents. In addition, increase in investment in development of neurothrombectomy devices by key players is expected to notably contribute toward the market expansion. For instance, according to the National Center for Health Statistics, every year, more than 795,000 people in the U.S. have a stroke. About 610,000 of these are first or new strokes. In addition, according to the Center for Disease Control and Prevention, approximately 87% of all strokes reported are ischemic stroke. For instance, according to the Southwestern Medical Center, about 795,000 people in the U.S. suffer from a stroke every year. Furthermore, according to the National Center for Biotechnology Information (NCBI), strokes occur more commonly in women than in men,
In addition, women who use oral contraceptives may be at an increased risk for blood clotting. Women who have a history of blood clots are over the age of 35 or smoke and continue to use contraceptives have an extremely high risk of developing blood clots. Therefore, increased used of contraceptive pills propels the growth of market. Moreover, increase in awareness about neurothrombectomy devices and surge in cases of inflammation of superficial vein, atherosclerosis, and ischemic stroke require neurothrombectomy as immediate treatment, thus propelling the market growth. In addition, technological advancements; launch of various products; adoption of various strategies among the key players such as acquisition, collaboration, and agreement drive the growth of the global neurothrombectomy devices market. For instance, Acandis GmbH announced that it has received European CE mark approval for its APERIO hybrid thrombectomy device in May 2019. APERIO hybrid thrombectomy device is intended for restoration of the arterial flow in patients diagnosed with ischemic stroke due to large intracranial vascular occlusion.
However, unfavorable reimbursements in emerging countries as well as complications or risks associated with neuro thrombectomy devices are expected to hamper market growth during the forecast period. The market growth of the neurothrombectomy devices is further restrained due to high cost of neurothrombectomy devices. On the contrary, the healthcare business is projected to witness growth due to surge in prevalence of venous thromboembolism, rise in cases of head injuries due to accidents, increase in incidence of ischemic stroke, rise in investments in development of neurothrombectomy devices, and surge in awareness about these devices.
The global neurothrombectomy devices market is segmented into product type, end user, and region. On the basis of product type, the market is classified into clot retrieval devices, aspiration devices, and snares. By end user, it is fragmented into hospitals, specialty clinics, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Acandis GmbH, Boston Scientific Corporation, Medtronic, Microvention Inc., Penumbra Inc., Phenox GmbH, Stryker Corporation, Teleflex, and Vesalio.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the neurothrombectomy devices market to identify the prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment across various regions.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region & country wise analysis is provided to understand the market trends and dynamics.
Key Market Segments
By Product Type
Clot Retrieval Devices
Aspiration Devices
Snares
By End User
Specialty Clinics
Hospitals
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Medtronic
Stryker Corporation
Acandis GmbH
Penumbra Inc.
Phenox GmbH
Vesalio
MicroVention Inc.
Boston Scientific Corporation
Teleflex Incorporated
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Clot Retrieval Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Aspiration Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Snares
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: NEUROTHROMBECTOMY DEVICES MARKET, BY END USER
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Hospitals
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Specialty Clinics
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: NEUROTHROMBECTOMY DEVICES MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Product Type
- 6.2.3 North America Market size and forecast, by End User
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Product Type
- 6.2.4.1.2 Market size and forecast, by End User
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Product Type
- 6.2.4.2.2 Market size and forecast, by End User
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Product Type
- 6.2.4.3.2 Market size and forecast, by End User
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Product Type
- 6.3.3 Europe Market size and forecast, by End User
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Product Type
- 6.3.4.1.2 Market size and forecast, by End User
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Product Type
- 6.3.4.2.2 Market size and forecast, by End User
- 6.3.4.3 U.K.
- 6.3.4.3.1 Market size and forecast, by Product Type
- 6.3.4.3.2 Market size and forecast, by End User
- 6.3.4.4 Italy
- 6.3.4.4.1 Market size and forecast, by Product Type
- 6.3.4.4.2 Market size and forecast, by End User
- 6.3.4.5 Spain
- 6.3.4.5.1 Market size and forecast, by Product Type
- 6.3.4.5.2 Market size and forecast, by End User
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Product Type
- 6.3.4.6.2 Market size and forecast, by End User
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Product Type
- 6.4.3 Asia-Pacific Market size and forecast, by End User
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 Japan
- 6.4.4.1.1 Market size and forecast, by Product Type
- 6.4.4.1.2 Market size and forecast, by End User
- 6.4.4.2 China
- 6.4.4.2.1 Market size and forecast, by Product Type
- 6.4.4.2.2 Market size and forecast, by End User
- 6.4.4.3 Australia
- 6.4.4.3.1 Market size and forecast, by Product Type
- 6.4.4.3.2 Market size and forecast, by End User
- 6.4.4.4 India
- 6.4.4.4.1 Market size and forecast, by Product Type
- 6.4.4.4.2 Market size and forecast, by End User
- 6.4.4.5 South Korea
- 6.4.4.5.1 Market size and forecast, by Product Type
- 6.4.4.5.2 Market size and forecast, by End User
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Market size and forecast, by Product Type
- 6.4.4.6.2 Market size and forecast, by End User
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Product Type
- 6.5.3 LAMEA Market size and forecast, by End User
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Product Type
- 6.5.4.1.2 Market size and forecast, by End User
- 6.5.4.2 Saudi Arabia
- 6.5.4.2.1 Market size and forecast, by Product Type
- 6.5.4.2.2 Market size and forecast, by End User
- 6.5.4.3 South Africa
- 6.5.4.3.1 Market size and forecast, by Product Type
- 6.5.4.3.2 Market size and forecast, by End User
- 6.5.4.4 Rest of LAMEA
- 6.5.4.4.1 Market size and forecast, by Product Type
- 6.5.4.4.2 Market size and forecast, by End User
- CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
- CHAPTER 8: COMPANY PROFILES
- 8.1 Medtronic
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 Stryker Corporation
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Acandis GmbH
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Penumbra Inc.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 Phenox GmbH
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Vesalio
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 MicroVention Inc.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Boston Scientific Corporation
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Teleflex Incorporated
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 2. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR CLOT RETRIEVAL DEVICES, BY REGION , 2021-2031,($MILLION)
- TABLE 3. NEUROTHROMBECTOMY DEVICES MARKET FOR CLOT RETRIEVAL DEVICES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 4. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR ASPIRATION DEVICES, BY REGION , 2021-2031,($MILLION)
- TABLE 5. NEUROTHROMBECTOMY DEVICES MARKET FOR ASPIRATION DEVICES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 6. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR SNARES, BY REGION , 2021-2031,($MILLION)
- TABLE 7. NEUROTHROMBECTOMY DEVICES MARKET FOR SNARES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 9. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
- TABLE 10. NEUROTHROMBECTOMY DEVICES MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 11. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2021-2031,($MILLION)
- TABLE 12. NEUROTHROMBECTOMY DEVICES MARKET FOR SPECIALTY CLINICS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 13. NEUROTHROMBECTOMY DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 14. NEUROTHROMBECTOMY DEVICES MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 15. NEUROTHROMBECTOMY DEVICES MARKET, BY REGION, 2021-2031,($MILLION)
- TABLE 16. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 17. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 18. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 19. U.S. NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 20. U.S. NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 21. CANADA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 22. CANADA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 23. MEXICO NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 24. MEXICO NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 25. EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 26. EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 27. EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 28. GERMANY NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 29. GERMANY NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 30. FRANCE NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 31. FRANCE NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 32. U.K. NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 33. U.K. NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 34. ITALY NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 35. ITALY NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 36. SPAIN NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 37. SPAIN NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 38. REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 39. REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 40. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 41. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 42. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 43. JAPAN NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 44. JAPAN NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 45. CHINA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 46. CHINA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 47. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 48. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 49. INDIA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 50. INDIA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 51. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 52. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 53. REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 54. REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 55. LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 56. LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 57. LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 58. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 59. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 60. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 61. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 62. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 63. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 64. REST OF LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 65. REST OF LAMEA NEUROTHROMBECTOMY DEVICES MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 66.MEDTRONIC: COMPANY SNAPSHOT
- TABLE 67.MEDTRONIC: OPERATING SEGMENTS
- TABLE 68.MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 69.MEDTRONIC: NET SALES,
- TABLE 70.MEDTRONIC: KEY STRATERGIES
- TABLE 71.STRYKER CORPORATION: COMPANY SNAPSHOT
- TABLE 72.STRYKER CORPORATION: OPERATING SEGMENTS
- TABLE 73.STRYKER CORPORATION: PRODUCT PORTFOLIO
- TABLE 74.STRYKER CORPORATION: NET SALES,
- TABLE 75.STRYKER CORPORATION: KEY STRATERGIES
- TABLE 76.ACANDIS GMBH: COMPANY SNAPSHOT
- TABLE 77.ACANDIS GMBH: OPERATING SEGMENTS
- TABLE 78.ACANDIS GMBH: PRODUCT PORTFOLIO
- TABLE 79.ACANDIS GMBH: NET SALES,
- TABLE 80.ACANDIS GMBH: KEY STRATERGIES
- TABLE 81.PENUMBRA INC.: COMPANY SNAPSHOT
- TABLE 82.PENUMBRA INC.: OPERATING SEGMENTS
- TABLE 83.PENUMBRA INC.: PRODUCT PORTFOLIO
- TABLE 84.PENUMBRA INC.: NET SALES,
- TABLE 85.PENUMBRA INC.: KEY STRATERGIES
- TABLE 86.PHENOX GMBH: COMPANY SNAPSHOT
- TABLE 87.PHENOX GMBH: OPERATING SEGMENTS
- TABLE 88.PHENOX GMBH: PRODUCT PORTFOLIO
- TABLE 89.PHENOX GMBH: NET SALES,
- TABLE 90.PHENOX GMBH: KEY STRATERGIES
- TABLE 91.VESALIO: COMPANY SNAPSHOT
- TABLE 92.VESALIO: OPERATING SEGMENTS
- TABLE 93.VESALIO: PRODUCT PORTFOLIO
- TABLE 94.VESALIO: NET SALES,
- TABLE 95.VESALIO: KEY STRATERGIES
- TABLE 96.MICROVENTION INC.: COMPANY SNAPSHOT
- TABLE 97.MICROVENTION INC.: OPERATING SEGMENTS
- TABLE 98.MICROVENTION INC.: PRODUCT PORTFOLIO
- TABLE 99.MICROVENTION INC.: NET SALES,
- TABLE 100.MICROVENTION INC.: KEY STRATERGIES
- TABLE 101.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 102.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 103.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 104.BOSTON SCIENTIFIC CORPORATION: NET SALES,
- TABLE 105.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 106.TELEFLEX INCORPORATED: COMPANY SNAPSHOT
- TABLE 107.TELEFLEX INCORPORATED: OPERATING SEGMENTS
- TABLE 108.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
- TABLE 109.TELEFLEX INCORPORATED: NET SALES,
- TABLE 110.TELEFLEX INCORPORATED: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION
- FIGURE 2.NEUROTHROMBECTOMY DEVICES MARKET,2021-2031
- FIGURE 3.NEUROTHROMBECTOMY DEVICES MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.NEUROTHROMBECTOMY DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.NEUROTHROMBECTOMY DEVICES MARKET,BY PRODUCT TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CLOT RETRIEVAL DEVICES NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ASPIRATION DEVICES NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SNARES NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
- FIGURE 16.NEUROTHROMBECTOMY DEVICES MARKET,BY END USER,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOSPITALS NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS NEUROTHROMBECTOMY DEVICES MARKET,2021-2031(%)
- FIGURE 20.NEUROTHROMBECTOMY DEVICES MARKET BY REGION,2021
- FIGURE 21.U.S. NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 22.CANADA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 23.MEXICO NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 24.GERMANY NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 25.FRANCE NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 26.U.K. NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 27.ITALY NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 28.SPAIN NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 29.REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 30.JAPAN NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 31.CHINA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 32.AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 33.INDIA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 34.SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 35.REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 36.BRAZIL NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 37.SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 38.SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 39.REST OF LAMEA NEUROTHROMBECTOMY DEVICES MARKET,2021-2031($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44.COMPETITIVE DASHBOARD
- FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 46.MEDTRONIC.: NET SALES ,($MILLION)
- FIGURE 47.STRYKER CORPORATION.: NET SALES ,($MILLION)
- FIGURE 48.ACANDIS GMBH.: NET SALES ,($MILLION)
- FIGURE 49.PENUMBRA INC..: NET SALES ,($MILLION)
- FIGURE 50.PHENOX GMBH.: NET SALES ,($MILLION)
- FIGURE 51.VESALIO.: NET SALES ,($MILLION)
- FIGURE 52.MICROVENTION INC..: NET SALES ,($MILLION)
- FIGURE 53.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 54.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook